Biltmore Family Office’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Sell |
3,264
-188
| -5% | -$64.4K | 0.16% | 98 |
|
|
2026
Q1 | $1.21M | Buy |
3,452
+376
| +12% | +$134K | 0.17% | 92 |
|
|
2025
Q4 | $1.01M | Buy |
3,076
+508
| +20% | +$161K | 0.14% | 101 |
|
|
2025
Q3 | $725K | Buy |
2,568
+193
| +8% | +$56K | 0.1% | 116 |
|
|
2025
Q2 | $663K | Sell |
2,375
-368
| -13% | -$104K | 0.11% | 108 |
|
|
2025
Q1 | $855K | Sell |
2,743
-38
| -1% | -$11.2K | 0.15% | 96 |
|
|
2024
Q4 | $725K | Sell |
2,781
-243
| -8% | -$72.1K | 0.12% | 99 |
|
|
2024
Q3 | $974K | Buy |
3,024
+133
| +5% | +$43.5K | 0.17% | 86 |
|
|
2024
Q2 | $903K | Buy |
2,891
+600
| +26% | +$176K | 0.17% | 85 |
|
|
2024
Q1 | $651K | Sell |
2,291
-42
| -2% | -$12.3K | 0.13% | 96 |
|
|
2023
Q4 | $672K | Hold |
2,333
| – | – | 0.14% | 95 |
|
|
2023
Q3 | $627K | Hold |
2,333
| – | – | 0.14% | 99 |
|
|
2023
Q2 | $518K | Buy |
2,333
+737
| +46% | +$171K | 0.11% | 106 |
|
|
2023
Q1 | $386K | Buy |
1,596
+49
| +3% | +$12K | 0.08% | 157 |
|
|
2022
Q4 | $406K | Sell |
1,547
-58
| -4% | -$15.5K | 0.08% | 150 |
|
|
2022
Q3 | $362K | Sell |
1,605
-122
| -7% | -$29.6K | 0.08% | 123 |
|
|
2022
Q2 | $420K | Sell |
1,727
-250
| -13% | -$61.3K | 0.1% | 120 |
|
|
2022
Q1 | $478K | Sell |
1,977
-166
| -8% | -$38.1K | 0.1% | 110 |
|
|
2021
Q4 | $482K | Buy |
2,143
+416
| +24% | +$87.8K | 0.09% | 128 |
|
|
2021
Q3 | $367K | Hold |
1,727
| – | – | 0.09% | 132 |
|
|
2021
Q2 | $421K | Sell |
1,727
-105
| -6% | -$25.8K | 0.12% | 118 |
|
|
2021
Q1 | $456K | Sell |
1,832
-1,000
| -35% | -$239K | 0.14% | 99 |
|
|
2020
Q4 | $651K | Buy |
2,832
+190
| +7% | +$43.8K | 0.2% | 75 |
|
|
2020
Q3 | $671K | Hold |
2,642
| – | – | 0.37% | 61 |
|
|
2020
Q2 | $623K | Hold |
2,642
| – | – | 0.38% | 68 |
|
|
2020
Q1 | $536K | Sell |
2,642
-77
| -3% | -$16.8K | 0.35% | 76 |
|
|
2019
Q4 | $655K | Buy |
2,719
+77
| +3% | +$17K | 0.26% | 81 |
|
|
2019
Q3 | $511K | Buy |
2,642
+952
| +56% | +$183K | 0.22% | 90 |
|
|
2019
Q2 | $311K | Sell |
1,690
-70
| -4% | -$12.5K | 0.17% | 108 |
|
|
2019
Q1 | $334K | Hold |
1,760
| – | – | 0.17% | 112 |
|
|
2018
Q4 | $343K | Buy |
1,760
+48
| +3% | +$9.36K | 0.19% | 108 |
|
|
2018
Q3 | $355K | Hold |
1,712
| – | – | 0.17% | 112 |
|
|
2018
Q2 | $316K | Sell |
1,712
-975
| -36% | -$172K | 0.16% | 112 |
|
|
2018
Q1 | $458K | Buy |
2,687
+870
| +48% | +$160K | 0.2% | 105 |
|
|
2017
Q4 | $316K | Buy |
+1,817
| New | +$322K | 0.14% | 120 |
|
Other funds holding AMGN
Biltmore Family Office's AMGN Position: Q2 2026 in Review
Biltmore Family Office reduced its Amgen (AMGN) stake by 5.4% in Q2 2026, selling an estimated $64.4K and leaving 3,264 shares worth $1.18M. The position accounts for 0.16% of the portfolio, ranked #98.
Biltmore Family Office first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.21M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Biltmore Family Office held 3,264 shares of Amgen worth $1.18M as of Q2 2026.
- Biltmore Family Office sold 188 Amgen shares in Q2 2026, an estimated $64.4K.
- Amgen made up 0.16% of Biltmore Family Office's portfolio in Q2 2026, its #98 holding.
- Biltmore Family Office first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- Biltmore Family Office's Amgen position peaked at $1.21M in Q1 2026.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Biltmore Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.